http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Dong Won Park ),( Misoo Chang ),( Gun Woo Koo ),( Tai Sun Park ),( Ji-yong Moon ),( Tae-hyung Kim ),( Jang Won Sohn ),( Ho Joo Yoon ),( Dong Ho Shin ),( Eun Woo Nam ),( Sang-heon Kim ) 대한결핵 및 호흡기학회 2016 대한결핵 및 호흡기학회 추계학술대회 초록집 Vol.121 No.-
Background: The increased risk of pulmonary tuberculosis (PTB) infection has been revealed among the patients with rheumatic diseases. However, it is not clear whether rheumatic diseases affect the risk of EPTB. We aimed to investigate the prevalence of both pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB) in patients with rheumatic diseases. Methods: We performed analysis from the Korean Health Insurance Review and Assessment Service (HIRA) database, spanning the period from January 2012 to December 2012. The database (HIRA-NPS-2012-0090) was based on random sampling of outpatients from whole population. Patients with PTB, EPTB, and rheumatic diseases were identified based on the International Classification of Disease-10 (ICD-10) diagnostic codes. Results: We identified 30,854 (2.17%) patients with rheumatic diseases of 1,422,551 cases, and the prevalence of all forms of TB in patients with rheumatic diseases was about 3.5 times higher than those without rheumatic diseases (1.72% vs. 0.49%, respectively). In addition, prevalence of PTB and EPTB were 1.34% and 0.38% in patients with rheumatic diseases, which were almost 3-5 times higher prevalence of PTB and EPTB in those without rheumatic diseases. Conclusions: This study found that the prevalence of both PTB and EPTB were higher among the patients with rheumatic diseases. Physicians should be alert to the possibility of TB in patients with rheumatic diseases, especially EPTB.